Showing results (181-190 of 344) with videos related to
Sort By:
Pageof 35
Physics in Medicine and Biology|August 7, 2012
Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatmentNing Wen, Carri Glide-Hurst, Teamour Nurushev, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II studyDavid S Ettinger, Brian A Berkey, Ross A Abrams, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31Miljenko V Pilepich, Kathryn Winter, Colleen A Lawton, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 2013
Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology surveyRitsuko Komaki, Najma Khalid, Corey J Langer, et al.Cancer|December 17, 2013
Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129Canhua Xiao, Alexandra Hanlon, Qiang Zhang, et al.Clinical Lung Cancer|December 8, 2016
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505)David E Gerber, James J Urbanic, Corey Langer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01Benjamin Movsas, Charles Scott, Corey Langer, et al.International Journal of Radiation Oncology, Biology, Physics|April 20, 2013
Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214Vinai Gondi, Rebecca Paulus, Deborah W Bruner, et al.Physics in Medicine and Biology|May 20, 2015
Contouring variability of human- and deformable-generated contours in radiotherapy for prostate cancerStephen J Gardner, Ning Wen, Jinkoo Kim, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Correlation of dose computed using different algorithms with local control following stereotactic ablative radiotherapy (SABR)-based treatment of non-small-cell lung cancerIndrin J Chetty, Suneetha Devpura, Dezhi Liu, et al.Pageof 35